aluates Reports

$ 0.0

Automative

Global Binge Eating Disorder Drug Market Research Report 2025

Published Date: August 2025

Report Code: QYRE-Auto-1B8892

China Binge Eating Disorder Drug Market Report Forecast 2021 2027

BUY CHAPTERS

Global Binge Eating Disorder Drug Market Research Report 2025

Code: QYRE-Auto-1B8892

Report

August 2025

Pages:86

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Roche

Chronos Therapeutics

Heptares

Novo Nordisk

Omeros Corp

Sunovion Pharmaceuticals

Opiant Pharmaceuticals

Binge Eating Disorder Drug Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Binge Eating Disorder Drug Market

The global market for Binge Eating Disorder Drug was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Binge eating disorder is a serious condition characterized by uncontrollable eating and resulting weight gain. The causes of binge-eating disorder are unknown. But family history, biological factors, long-term dieting and psychological issues increase risk. Signs and symptoms include eating unusually large amounts of food, frequently eating alone, feeling that eating behavior is out of control and experiencing depression and anxiety. Treatment includes psychOthersapy, medications and behavioral weight-loss programs.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Binge Eating Disorder Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Binge Eating Disorder Drug.

The Binge Eating Disorder Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Binge Eating Disorder Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Binge Eating Disorder Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Binge Eating Disorder Drug Market Report

Report Metric	Details
Report Name	Binge Eating Disorder Drug Market
CAGR	5%
Segment by Type	Antidepressants Anticonvulsants Anti-obesity Medications
Segment by Application	Retail Pharmacies Hospital Pharmacies Online Pharmacies
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Roche, Chronos Therapeutics, Heptares, Novo Nordisk, Omeros Corp, Sunovion Pharmaceuticals, Opiant Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Binge Eating Disorder Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Binge Eating Disorder Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Binge Eating Disorder Drug Market report?

Ans: The main players in the Binge Eating Disorder Drug Market are Roche, Chronos Therapeutics, Heptares, Novo Nordisk, Omeros Corp, Sunovion Pharmaceuticals, Opiant Pharmaceuticals

What are the Application segmentation covered in the Binge Eating Disorder Drug Market report?

Ans: The Applications covered in the Binge Eating Disorder Drug Market report are Retail Pharmacies, Hospital Pharmacies, Online Pharmacies

What are the Type segmentation covered in the Binge Eating Disorder Drug Market report?

Ans: The Types covered in the Binge Eating Disorder Drug Market report are Antidepressants, Anticonvulsants, Anti-obesity Medications

1 Binge Eating Disorder Drug Market Overview

1.1 Product Definition

1.2 Binge Eating Disorder Drug by Type

1.2.1 Global Binge Eating Disorder Drug Market Value Comparison by Type (2024 VS 2031)

1.2.2 Antidepressants

1.2.3 Anticonvulsants

1.2.4 Anti-obesity Medications

1.3 Binge Eating Disorder Drug by Application

1.3.1 Global Binge Eating Disorder Drug Market Value by Application (2024 VS 2031)

1.3.2 Retail Pharmacies

1.3.3 Hospital Pharmacies

1.3.4 Online Pharmacies

1.4 Global Binge Eating Disorder Drug Market Size Estimates and Forecasts

1.4.1 Global Binge Eating Disorder Drug Revenue 2020-2031

1.4.2 Global Binge Eating Disorder Drug Sales 2020-2031

1.4.3 Global Binge Eating Disorder Drug Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Binge Eating Disorder Drug Market Competition by Manufacturers

2.1 Global Binge Eating Disorder Drug Sales Market Share by Manufacturers (2020-2025)

2.2 Global Binge Eating Disorder Drug Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Binge Eating Disorder Drug Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Binge Eating Disorder Drug, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Binge Eating Disorder Drug, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Binge Eating Disorder Drug, Product Type & Application

2.7 Global Key Manufacturers of Binge Eating Disorder Drug, Date of Enter into This Industry

2.8 Global Binge Eating Disorder Drug Market Competitive Situation and Trends

2.8.1 Global Binge Eating Disorder Drug Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Binge Eating Disorder Drug Players Market Share by Revenue

2.8.3 Global Binge Eating Disorder Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Binge Eating Disorder Drug Market Scenario by Region

3.1 Global Binge Eating Disorder Drug Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Binge Eating Disorder Drug Sales by Region: 2020-2031

3.2.1 Global Binge Eating Disorder Drug Sales by Region: 2020-2025

3.2.2 Global Binge Eating Disorder Drug Sales by Region: 2026-2031

3.3 Global Binge Eating Disorder Drug Revenue by Region: 2020-2031

3.3.1 Global Binge Eating Disorder Drug Revenue by Region: 2020-2025

3.3.2 Global Binge Eating Disorder Drug Revenue by Region: 2026-2031

3.4 North America Binge Eating Disorder Drug Market Facts & Figures by Country

3.4.1 North America Binge Eating Disorder Drug Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Binge Eating Disorder Drug Sales by Country (2020-2031)

3.4.3 North America Binge Eating Disorder Drug Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Binge Eating Disorder Drug Market Facts & Figures by Country

3.5.1 Europe Binge Eating Disorder Drug Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Binge Eating Disorder Drug Sales by Country (2020-2031)

3.5.3 Europe Binge Eating Disorder Drug Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Binge Eating Disorder Drug Market Facts & Figures by Region

3.6.1 Asia Pacific Binge Eating Disorder Drug Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Binge Eating Disorder Drug Sales by Region (2020-2031)

3.6.3 Asia Pacific Binge Eating Disorder Drug Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Binge Eating Disorder Drug Market Facts & Figures by Country

3.7.1 Latin America Binge Eating Disorder Drug Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Binge Eating Disorder Drug Sales by Country (2020-2031)

3.7.3 Latin America Binge Eating Disorder Drug Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Binge Eating Disorder Drug Market Facts & Figures by Country

3.8.1 Middle East and Africa Binge Eating Disorder Drug Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Binge Eating Disorder Drug Sales by Country (2020-2031)

3.8.3 Middle East and Africa Binge Eating Disorder Drug Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Binge Eating Disorder Drug Sales by Type (2020-2031)

4.1.1 Global Binge Eating Disorder Drug Sales by Type (2020-2025)

4.1.2 Global Binge Eating Disorder Drug Sales by Type (2026-2031)

4.1.3 Global Binge Eating Disorder Drug Sales Market Share by Type (2020-2031)

4.2 Global Binge Eating Disorder Drug Revenue by Type (2020-2031)

4.2.1 Global Binge Eating Disorder Drug Revenue by Type (2020-2025)

4.2.2 Global Binge Eating Disorder Drug Revenue by Type (2026-2031)

4.2.3 Global Binge Eating Disorder Drug Revenue Market Share by Type (2020-2031)

4.3 Global Binge Eating Disorder Drug Price by Type (2020-2031)

5 Segment by Application

5.1 Global Binge Eating Disorder Drug Sales by Application (2020-2031)

5.1.1 Global Binge Eating Disorder Drug Sales by Application (2020-2025)

5.1.2 Global Binge Eating Disorder Drug Sales by Application (2026-2031)

5.1.3 Global Binge Eating Disorder Drug Sales Market Share by Application (2020-2031)

5.2 Global Binge Eating Disorder Drug Revenue by Application (2020-2031)

5.2.1 Global Binge Eating Disorder Drug Revenue by Application (2020-2025)

5.2.2 Global Binge Eating Disorder Drug Revenue by Application (2026-2031)

5.2.3 Global Binge Eating Disorder Drug Revenue Market Share by Application (2020-2031)

5.3 Global Binge Eating Disorder Drug Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Roche

6.1.1 Roche Company Information

6.1.2 Roche Description and Business Overview

6.1.3 Roche Binge Eating Disorder Drug Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Roche Binge Eating Disorder Drug Product Portfolio

6.1.5 Roche Recent Developments/Updates

6.2 Chronos Therapeutics

6.2.1 Chronos Therapeutics Company Information

6.2.2 Chronos Therapeutics Description and Business Overview

6.2.3 Chronos Therapeutics Binge Eating Disorder Drug Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Chronos Therapeutics Binge Eating Disorder Drug Product Portfolio

6.2.5 Chronos Therapeutics Recent Developments/Updates

6.3 Heptares

6.3.1 Heptares Company Information

6.3.2 Heptares Description and Business Overview

6.3.3 Heptares Binge Eating Disorder Drug Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Heptares Binge Eating Disorder Drug Product Portfolio

6.3.5 Heptares Recent Developments/Updates

6.4 Novo Nordisk

6.4.1 Novo Nordisk Company Information

6.4.2 Novo Nordisk Description and Business Overview

6.4.3 Novo Nordisk Binge Eating Disorder Drug Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Novo Nordisk Binge Eating Disorder Drug Product Portfolio

6.4.5 Novo Nordisk Recent Developments/Updates

6.5 Omeros Corp

6.5.1 Omeros Corp Company Information

6.5.2 Omeros Corp Description and Business Overview

6.5.3 Omeros Corp Binge Eating Disorder Drug Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Omeros Corp Binge Eating Disorder Drug Product Portfolio

6.5.5 Omeros Corp Recent Developments/Updates

6.6 Sunovion Pharmaceuticals

6.6.1 Sunovion Pharmaceuticals Company Information

6.6.2 Sunovion Pharmaceuticals Description and Business Overview

6.6.3 Sunovion Pharmaceuticals Binge Eating Disorder Drug Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Sunovion Pharmaceuticals Binge Eating Disorder Drug Product Portfolio

6.6.5 Sunovion Pharmaceuticals Recent Developments/Updates

6.7 Opiant Pharmaceuticals

6.7.1 Opiant Pharmaceuticals Company Information

6.7.2 Opiant Pharmaceuticals Description and Business Overview

6.7.3 Opiant Pharmaceuticals Binge Eating Disorder Drug Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Opiant Pharmaceuticals Binge Eating Disorder Drug Product Portfolio

6.7.5 Opiant Pharmaceuticals Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Binge Eating Disorder Drug Industry Chain Analysis

7.2 Binge Eating Disorder Drug Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Binge Eating Disorder Drug Production Mode & Process Analysis

7.4 Binge Eating Disorder Drug Sales and Marketing

7.4.1 Binge Eating Disorder Drug Sales Channels

7.4.2 Binge Eating Disorder Drug Distributors

7.5 Binge Eating Disorder Drug Customer Analysis

8 Binge Eating Disorder Drug Market Dynamics

8.1 Binge Eating Disorder Drug Industry Trends

8.2 Binge Eating Disorder Drug Market Drivers

8.3 Binge Eating Disorder Drug Market Challenges

8.4 Binge Eating Disorder Drug Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Roche

Chronos Therapeutics

Heptares

Novo Nordisk

Omeros Corp

Sunovion Pharmaceuticals

Opiant Pharmaceuticals

List of Tables

Table 1. Global Binge Eating Disorder Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Binge Eating Disorder Drug Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Binge Eating Disorder Drug Market Competitive Situation by Manufacturers in 2024

Table 4. Global Binge Eating Disorder Drug Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Binge Eating Disorder Drug Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Binge Eating Disorder Drug Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Binge Eating Disorder Drug Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Binge Eating Disorder Drug Average Price (USD/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Binge Eating Disorder Drug, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Binge Eating Disorder Drug, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Binge Eating Disorder Drug, Product Type & Application

Table 12. Global Key Manufacturers of Binge Eating Disorder Drug, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Binge Eating Disorder Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Binge Eating Disorder Drug as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Binge Eating Disorder Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Binge Eating Disorder Drug Sales by Region (2020-2025) & (K Units)

Table 18. Global Binge Eating Disorder Drug Sales Market Share by Region (2020-2025)

Table 19. Global Binge Eating Disorder Drug Sales by Region (2026-2031) & (K Units)

Table 20. Global Binge Eating Disorder Drug Sales Market Share by Region (2026-2031)

Table 21. Global Binge Eating Disorder Drug Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Binge Eating Disorder Drug Revenue Market Share by Region (2020-2025)

Table 23. Global Binge Eating Disorder Drug Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Binge Eating Disorder Drug Revenue Market Share by Region (2026-2031)

Table 25. North America Binge Eating Disorder Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Binge Eating Disorder Drug Sales by Country (2020-2025) & (K Units)

Table 27. North America Binge Eating Disorder Drug Sales by Country (2026-2031) & (K Units)

Table 28. North America Binge Eating Disorder Drug Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Binge Eating Disorder Drug Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Binge Eating Disorder Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Binge Eating Disorder Drug Sales by Country (2020-2025) & (K Units)

Table 32. Europe Binge Eating Disorder Drug Sales by Country (2026-2031) & (K Units)

Table 33. Europe Binge Eating Disorder Drug Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Binge Eating Disorder Drug Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Binge Eating Disorder Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Binge Eating Disorder Drug Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Binge Eating Disorder Drug Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Binge Eating Disorder Drug Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Binge Eating Disorder Drug Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Binge Eating Disorder Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Binge Eating Disorder Drug Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Binge Eating Disorder Drug Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Binge Eating Disorder Drug Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Binge Eating Disorder Drug Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Binge Eating Disorder Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Binge Eating Disorder Drug Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Binge Eating Disorder Drug Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Binge Eating Disorder Drug Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Binge Eating Disorder Drug Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Binge Eating Disorder Drug Sales (K Units) by Type (2020-2025)

Table 51. Global Binge Eating Disorder Drug Sales (K Units) by Type (2026-2031)

Table 52. Global Binge Eating Disorder Drug Sales Market Share by Type (2020-2025)

Table 53. Global Binge Eating Disorder Drug Sales Market Share by Type (2026-2031)

Table 54. Global Binge Eating Disorder Drug Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Binge Eating Disorder Drug Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Binge Eating Disorder Drug Revenue Market Share by Type (2020-2025)

Table 57. Global Binge Eating Disorder Drug Revenue Market Share by Type (2026-2031)

Table 58. Global Binge Eating Disorder Drug Price (USD/Unit) by Type (2020-2025)

Table 59. Global Binge Eating Disorder Drug Price (USD/Unit) by Type (2026-2031)

Table 60. Global Binge Eating Disorder Drug Sales (K Units) by Application (2020-2025)

Table 61. Global Binge Eating Disorder Drug Sales (K Units) by Application (2026-2031)

Table 62. Global Binge Eating Disorder Drug Sales Market Share by Application (2020-2025)

Table 63. Global Binge Eating Disorder Drug Sales Market Share by Application (2026-2031)

Table 64. Global Binge Eating Disorder Drug Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Binge Eating Disorder Drug Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Binge Eating Disorder Drug Revenue Market Share by Application (2020-2025)

Table 67. Global Binge Eating Disorder Drug Revenue Market Share by Application (2026-2031)

Table 68. Global Binge Eating Disorder Drug Price (USD/Unit) by Application (2020-2025)

Table 69. Global Binge Eating Disorder Drug Price (USD/Unit) by Application (2026-2031)

Table 70. Roche Company Information

Table 71. Roche Description and Business Overview

Table 72. Roche Binge Eating Disorder Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 73. Roche Binge Eating Disorder Drug Product

Table 74. Roche Recent Developments/Updates

Table 75. Chronos Therapeutics Company Information

Table 76. Chronos Therapeutics Description and Business Overview

Table 77. Chronos Therapeutics Binge Eating Disorder Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 78. Chronos Therapeutics Binge Eating Disorder Drug Product

Table 79. Chronos Therapeutics Recent Developments/Updates

Table 80. Heptares Company Information

Table 81. Heptares Description and Business Overview

Table 82. Heptares Binge Eating Disorder Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 83. Heptares Binge Eating Disorder Drug Product

Table 84. Heptares Recent Developments/Updates

Table 85. Novo Nordisk Company Information

Table 86. Novo Nordisk Description and Business Overview

Table 87. Novo Nordisk Binge Eating Disorder Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 88. Novo Nordisk Binge Eating Disorder Drug Product

Table 89. Novo Nordisk Recent Developments/Updates

Table 90. Omeros Corp Company Information

Table 91. Omeros Corp Description and Business Overview

Table 92. Omeros Corp Binge Eating Disorder Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 93. Omeros Corp Binge Eating Disorder Drug Product

Table 94. Omeros Corp Recent Developments/Updates

Table 95. Sunovion Pharmaceuticals Company Information

Table 96. Sunovion Pharmaceuticals Description and Business Overview

Table 97. Sunovion Pharmaceuticals Binge Eating Disorder Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 98. Sunovion Pharmaceuticals Binge Eating Disorder Drug Product

Table 99. Sunovion Pharmaceuticals Recent Developments/Updates

Table 100. Opiant Pharmaceuticals Company Information

Table 101. Opiant Pharmaceuticals Description and Business Overview

Table 102. Opiant Pharmaceuticals Binge Eating Disorder Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 103. Opiant Pharmaceuticals Binge Eating Disorder Drug Product

Table 104. Opiant Pharmaceuticals Recent Developments/Updates

Table 105. Key Raw Materials Lists

Table 106. Raw Materials Key Suppliers Lists

Table 107. Binge Eating Disorder Drug Distributors List

Table 108. Binge Eating Disorder Drug Customers List

Table 109. Binge Eating Disorder Drug Market Trends

Table 110. Binge Eating Disorder Drug Market Drivers

Table 111. Binge Eating Disorder Drug Market Challenges

Table 112. Binge Eating Disorder Drug Market Restraints

Table 113. Research Programs/Design for This Report

Table 114. Key Data Information from Secondary Sources

Table 115. Key Data Information from Primary Sources

Table 116. Authors List of This Report

List of Figures

Figure 1. Product Picture of Binge Eating Disorder Drug

Figure 2. Global Binge Eating Disorder Drug Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Binge Eating Disorder Drug Market Share by Type: 2024 & 2031

Figure 4. Antidepressants Product Picture

Figure 5. Anticonvulsants Product Picture

Figure 6. Anti-obesity Medications Product Picture

Figure 7. Global Binge Eating Disorder Drug Market Value by Application (2020-2031) & (US$ Million)

Figure 8. Global Binge Eating Disorder Drug Market Share by Application: 2024 & 2031

Figure 9. Retail Pharmacies

Figure 10. Hospital Pharmacies

Figure 11. Online Pharmacies

Figure 12. Global Binge Eating Disorder Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Binge Eating Disorder Drug Market Size (2020-2031) & (US$ Million)

Figure 14. Global Binge Eating Disorder Drug Sales (2020-2031) & (K Units)

Figure 15. Global Binge Eating Disorder Drug Average Price (USD/Unit) & (2020-2031)

Figure 16. Binge Eating Disorder Drug Report Years Considered

Figure 17. Binge Eating Disorder Drug Sales Share by Manufacturers in 2024

Figure 18. Global Binge Eating Disorder Drug Revenue Share by Manufacturers in 2024

Figure 19. Global 5 and 10 Largest Binge Eating Disorder Drug Players: Market Share by Revenue in Binge Eating Disorder Drug in 2024

Figure 20. Binge Eating Disorder Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 21. Global Binge Eating Disorder Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 22. North America Binge Eating Disorder Drug Sales Market Share by Country (2020-2031)

Figure 23. North America Binge Eating Disorder Drug Revenue Market Share by Country (2020-2031)

Figure 24. U.S. Binge Eating Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Canada Binge Eating Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Europe Binge Eating Disorder Drug Sales Market Share by Country (2020-2031)

Figure 27. Europe Binge Eating Disorder Drug Revenue Market Share by Country (2020-2031)

Figure 28. Germany Binge Eating Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. France Binge Eating Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. U.K. Binge Eating Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Italy Binge Eating Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Russia Binge Eating Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Asia Pacific Binge Eating Disorder Drug Sales Market Share by Region (2020-2031)

Figure 34. Asia Pacific Binge Eating Disorder Drug Revenue Market Share by Region (2020-2031)

Figure 35. China Binge Eating Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Japan Binge Eating Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. South Korea Binge Eating Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. India Binge Eating Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Australia Binge Eating Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Taiwan Binge Eating Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Indonesia Binge Eating Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Thailand Binge Eating Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Malaysia Binge Eating Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Philippines Binge Eating Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Latin America Binge Eating Disorder Drug Sales Market Share by Country (2020-2031)

Figure 46. Latin America Binge Eating Disorder Drug Revenue Market Share by Country (2020-2031)

Figure 47. Mexico Binge Eating Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Brazil Binge Eating Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Argentina Binge Eating Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Middle East and Africa Binge Eating Disorder Drug Sales Market Share by Country (2020-2031)

Figure 51. Middle East and Africa Binge Eating Disorder Drug Revenue Market Share by Country (2020-2031)

Figure 52. Turkey Binge Eating Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Saudi Arabia Binge Eating Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. U.A.E Binge Eating Disorder Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. Global Sales Market Share of Binge Eating Disorder Drug by Type (2020-2031)

Figure 56. Global Revenue Market Share of Binge Eating Disorder Drug by Type (2020-2031)

Figure 57. Global Binge Eating Disorder Drug Price (USD/Unit) by Type (2020-2031)

Figure 58. Global Sales Market Share of Binge Eating Disorder Drug by Application (2020-2031)

Figure 59. Global Revenue Market Share of Binge Eating Disorder Drug by Application (2020-2031)

Figure 60. Global Binge Eating Disorder Drug Price (USD/Unit) by Application (2020-2031)

Figure 61. Binge Eating Disorder Drug Value Chain

Figure 62. Channels of Distribution (Direct Vs Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions